STOCK TITAN

Form 4: Reid Martin Luther reports multiple insider transactions in BCPC

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Reid Martin Luther reported multiple insider transaction types in a Form 4 filing for BCPC. The filing lists transactions totaling 7,900 shares at a weighted average price of $178.57 per share. Following the reported transactions, holdings were 9,073 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reid Martin Luther

(Last) (First) (Middle)
C/O BALCHEM CORPORATION
5 PARAGON DRIVE

(Street)
MONTVALE NJ 07645

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP Chief Supply Chain Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/11/2026 A 940(1) A $0 7,915 D
Common Stock 02/11/2026 A 2,359(2) A $0 10,274 D
Common Stock 02/11/2026 F 1,085(3) D $178.68 9,189 D
Common Stock 02/12/2026 F 116(4) D $177.49 9,073 D
Common Stock 542 I 401(k) Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $178.68 02/11/2026 A 3,400 (5) 02/11/2036 Common Stock 3,400 $0 3,400 D
Explanation of Responses:
1. Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
2. Represents the vesting of performance stock units (includes 39 dividend equivalent shares) for the 2023-2025 performance period.
3. 1,085 of the 2,359 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
4. Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
5. Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
/s/ Travis Larsen, Attorney in Fact for Martin Luther Reid 02/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did BCPC executive Martin Luther Reid report?

Martin Luther Reid reported equity grants, vesting, and tax-withholding disposals. He received restricted stock, vested performance stock units, and a new stock option grant, while shares were withheld and disposed of solely to cover tax liabilities arising from these vesting events.

How many Balchem (BCPC) shares did Martin Luther Reid acquire in these transactions?

Reid acquired 3,299 Balchem common shares through equity awards. This included 940 restricted shares and 2,359 shares from vested performance stock units for the 2023–2025 period, all at $0 per share as part of his compensation package.

What stock option grant did Martin Luther Reid receive from Balchem (BCPC)?

Reid received a grant of 3,400 Balchem stock options at a $178.68 exercise price. The options vest over three years: 20% in year one, 40% in year two, and 40% in year three, providing staged long-term incentive alignment with company performance.

Were Martin Luther Reid’s Balchem (BCPC) share disposals open-market sales?

No, the reported disposals were tax-withholding transactions. A total of 1,085 shares at $178.68 and 116 shares at $177.49 were withheld and disposed of to satisfy tax obligations triggered by equity vesting, not discretionary open-market selling.

How many Balchem (BCPC) shares does Martin Luther Reid own after these transactions?

After the transactions, Reid directly owned 9,073 Balchem common shares. In addition, he held 542 shares indirectly through a 401(k) plan and 3,400 stock options, reflecting his ongoing equity-based stake in the company’s future performance.

How do Martin Luther Reid’s restricted Balchem (BCPC) shares vest over time?

The restricted stock vests over a three-year schedule. Vesting occurs 25% on the first anniversary of the grant date, 25% on the second anniversary, and 50% on the third anniversary, subject to transfer restrictions under the Restricted Stock Grant Agreement.
Balchem Corp

NASDAQ:BCPC

BCPC Rankings

BCPC Latest News

BCPC Latest SEC Filings

BCPC Stock Data

5.75B
32.21M
0.37%
90.95%
1.44%
Specialty Chemicals
Chemicals & Allied Products
Link
United States
MONTVALE